• Lipid Nanoparticle Design Shapes mRNA Delivery and Immunogen

  2026-05-09

  This study demonstrates that the structure of lipid nanoparticles and the route of administration critically influence the efficacy and safety of mRNA delivery during pregnancy. Mechanistic insights clarify how specific LNP features affect transfection efficiency, innate immune responses, and maternal-fetal outcomes, guiding future therapeutic designs for pregnancy-related disorders.

• Pexidartinib (PLX3397): Targeted CSF1R Inhibitor for Oncolog

  2026-05-08

  Pexidartinib (PLX3397) is a potent, selective CSF1R inhibitor that modulates tumor-associated macrophages, enabling tumor microenvironment research and apoptotic assays. APExBIO provides this molecule for preclinical oncology workflows, supporting reproducible, high-specificity macrophage modulation.

• MEK1/2 and c-Myc-Max Control of TERT Transcription in hESCs

  2026-05-08

  This study uncovers a cooperative mechanism between MEK1/2 kinases and the c-Myc:MAX complex in preventing polycomb-mediated repression of TERT, the telomerase catalytic subunit gene, in human pluripotent stem cells. These findings clarify key epigenetic and transcriptional processes regulating telomerase, with implications for stem cell biology and telomere-related disease research.

• A-1210477: Next-Generation MCL-1 Inhibitor for Functional Ca

  2026-05-07

  Explore how the selective MCL-1 inhibitor A-1210477 enables advanced, mechanistically informed apoptosis induction in cancer cells. This in-depth article reveals unique experimental considerations and clinical insights beyond standard apoptosis assays.

• Sulfo-NHS-SS-Biotin: Precision Biotinylation for Protein Pur

  2026-05-07

  Sulfo-NHS-SS-Biotin empowers surface-selective, reversible protein labeling with unmatched workflow flexibility—transforming affinity purification, proteostasis, and interactome mapping. Discover experimentally validated protocols, troubleshooting strategies, and emerging applications that set this cleavable biotin disulfide N-hydroxysulfosuccinimide ester apart.

• Energy Deficiency, ATG4B, and DNA Repair in Leukemia Progres

  2026-05-06

  This study identifies a mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). The authors reveal that nuclear translocation of ATG4B inhibits PRMT1-mediated methylation of MRE11, promoting genomic instability and disease progression, highlighting new therapeutic vulnerabilities in cancer metabolism.

• Epalrestat: Aldose Reductase Inhibitor for Metabolic Disease

  2026-05-06

  Epalrestat from APExBIO enables precise inhibition of the polyol pathway and potent activation of antioxidant defenses, empowering advanced research in diabetic complications, neurodegeneration, and emerging cancer metabolism models. Its high purity, reproducible solubility in DMSO, and validated mechanism make it a standout choice for oxidative stress and metabolic pathway studies.

• Tioconazole: Mechanistic Insights and Next-Gen Antifungal Re

  2026-05-05

  Explore how Tioconazole, a leading antifungal medication, offers novel mechanistic insights for advanced antifungal drug development and fungal infection models. This article delivers a scientific deep dive beyond conventional workflows.

• Ezh2 Regulates Inflammasome Activation via lncRNA Neat1 Cont

  2026-05-05

  This study elucidates an epigenetic mechanism by which Ezh2 modulates inflammasome activation through transcriptional regulation of the lncRNA Neat1, competing with p53 at the promoter level. These findings advance our understanding of innate immune regulation and provide a framework for dissecting phosphorylation-dependent signaling in inflammasome biology.

• Bile Acid Metabolism Subtypes Define Prognostic Markers in C

  2026-05-04

  Feng et al. (2026) introduce a molecular subtyping strategy for colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as key markers of immune dysfunction and prognosis. Their integrative approach refines the understanding of the tumor immune microenvironment and offers potential targets for stratified therapies.

• NMDA Receptor Control of GABA Release by Parvalbumin Interne

  2026-05-04

  This study demonstrates that NMDA receptor signaling is essential for the maturation of Cav2.1 channel-dependent GABA release from neocortical parvalbumin interneurons. The findings clarify a mechanistic link between early-life NMDA receptor hypofunction and disrupted inhibitory transmission, with implications for understanding schizophrenia-like circuit pathophysiology.

• CAY10499: Unlocking Lipase Inhibition for Metabolic Assay In

  2026-05-03

  Explore how CAY10499, a potent inhibitor of human hormone sensitive lipase, enables new frontiers in lipid metabolism and macrophage differentiation research. This article uniquely connects advanced enzymology with tumor microenvironment insights for translational applications.

• Tioconazole in Translational Antifungal Research: Mechanisms

  2026-05-02

  This thought-leadership article explores the mechanistic role of Tioconazole as an antifungal medication, integrating emerging insights on metabolic-genomic interplay to guide translational researchers. By drawing on recent findings in cancer metabolism and DNA repair, the article offers actionable strategic guidance for antifungal drug development, experimental validation, and model fidelity. It also positions APExBIO’s Tioconazole as a high-purity research tool that bridges metabolic disruption with antifungal efficacy, differentiating this content from standard product pages.

• Losmapimod (GW856553X): Conformational Insights and Translat

  2026-05-01

  Explore the unique conformational mechanisms of Losmapimod, a selective p38 MAPK inhibitor, and how its dual-action enhances inflammation signaling modulation and vascular function. This article delivers an advanced, evidence-driven perspective distinct from standard reviews.

• ISR Inhibition Prevents Accelerated Forgetting in Epilepsy M

  2026-05-01

  This study demonstrates that pharmacological inhibition of the integrated stress response (ISR) by ISRIB prevents both natural and epilepsy-associated accelerated forgetting in mice. The findings provide mechanistic insight into memory decay and highlight ISR modulation as a promising research direction for cognitive decline in neurological diseases.

12907 records 1/861 page Next 12345 下5页 Last page